40
Participants
Start Date
March 1, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
December 31, 2026
Psilocybin 25mg
Psilocybin PEX010 is an investigational drug provided in capsule form, containing a 25 mg dose of synthetic psilocybin. The product is manufactured under Good Manufacturing Practice (GMP) standards to ensure purity, potency, and consistency. Each participant will receive a single oral dose of 25 mg psilocybin in a hydroxypropyl methylcellulose (HPMC) capsule. The intervention is administered once during the study session, with the effects expected to last approximately 4 to 6 hours.
RECRUITING
University College London, London
University College, London
OTHER